Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,522
archived clinical trials in
Chronic Pain

A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Buffalo, NY
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Buffalo, NY
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Hickory, NC
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Hickory, NC
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Cincinnati, OH
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Cincinnati, OH
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Cincinnati, OH
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Toledo, OH
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Toledo, OH
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Oklahoma, OK
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Oklahoma, OK
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Altoona, PA
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Altoona, PA
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Duncansville, PA
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Duncansville, PA
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Mount Pleasant, SC
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Dallas, TX
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Plano, TX
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Plano, TX
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
San Antonio, TX
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
San Antonio, TX
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Huntsville, AL
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Huntsville, AL
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Fresno, CA
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Fresno, CA
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Oldsmar, FL
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Oldsmar, FL
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
West Palm Beach, FL
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Chicago, IL
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Wichita, KA
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Wichita, KA
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Watertown, MA
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Watertown, MA
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Hartsdale, NY
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Hartsdale, NY
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Dayton, OH
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated:  4/18/2016
mi
from
Smithfield, PA
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
GSK Investigational Site
mi
from
Smithfield, PA
Click here to add this to my saved trials
Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel
RC11C3, Pilot Placebo-Controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome
Status: Enrolling
Updated:  4/18/2016
mi
from
Rochester, MN
Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel
RC11C3, Pilot Placebo-Controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome
Status: Enrolling
Updated: 4/18/2016
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Status: Enrolling
Updated:  4/20/2016
mi
from
Portland, OR
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Status: Enrolling
Updated: 4/20/2016
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Status: Enrolling
Updated:  4/20/2016
mi
from
Portland, OR
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Status: Enrolling
Updated: 4/20/2016
Planned Parenthood of the Columbia Willamette
mi
from
Portland, OR
Click here to add this to my saved trials
Effects of a Patient Driven Assessment Process With Complex Pain Patients
Effects of a Patient Driven Assessment Process With Complex Pain Patients (PDAP)
Status: Enrolling
Updated:  4/20/2016
mi
from
Portland, OR
Effects of a Patient Driven Assessment Process With Complex Pain Patients
Effects of a Patient Driven Assessment Process With Complex Pain Patients (PDAP)
Status: Enrolling
Updated: 4/20/2016
Kaiser Permanente Center for Health Research
mi
from
Portland, OR
Click here to add this to my saved trials
Ear Acupuncture for Pain Associated With Ambulatory Arthroscopic Knee Surgery
Ear Acupuncture for Post-operative Pain Associated With Ambulatory Arthroscopic Knee Surgery - A Randomized Controlled Trial
Status: Enrolling
Updated:  5/2/2016
mi
from
Nellis ABF, NV
Ear Acupuncture for Pain Associated With Ambulatory Arthroscopic Knee Surgery
Ear Acupuncture for Post-operative Pain Associated With Ambulatory Arthroscopic Knee Surgery - A Randomized Controlled Trial
Status: Enrolling
Updated: 5/2/2016
Mike O'Callaghan Federal Hospital
mi
from
Nellis ABF, NV
Click here to add this to my saved trials
Bupivacaine Injections Into Uterosacral Ligaments During Robotic Assisted Total Hysterectomies
Effectiveness of Bupivacaine With Epinephrine Injections Into the Uterosacral Ligaments for Post-operative Pain Control and the Use of Narcotic Pain Medication Following Robotic Assisted Total Hysterectomies
Status: Enrolling
Updated:  5/4/2016
mi
from
Farmington Hills, MI
Bupivacaine Injections Into Uterosacral Ligaments During Robotic Assisted Total Hysterectomies
Effectiveness of Bupivacaine With Epinephrine Injections Into the Uterosacral Ligaments for Post-operative Pain Control and the Use of Narcotic Pain Medication Following Robotic Assisted Total Hysterectomies
Status: Enrolling
Updated: 5/4/2016
Botsford General Hospital
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Safety Study of Deep Brain Stimulation to Manage Thalamic Pain Syndrome
Deep Brain Stimulation for Thalamic Pain Syndrome
Status: Enrolling
Updated:  5/23/2016
mi
from
Cleveland, OH
Safety Study of Deep Brain Stimulation to Manage Thalamic Pain Syndrome
Deep Brain Stimulation for Thalamic Pain Syndrome
Status: Enrolling
Updated: 5/23/2016
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Long Beach, CA
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Long Beach Memorial Medical Center
mi
from
Long Beach, CA
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Los Angeles, CA
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Children's Health Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Los Angeles, CA
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Aurora, CO
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Hartford, CT
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Connecticut Children's Medical Center
mi
from
Hartford, CT
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Washington,
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Howard University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Miami, FL
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Jackson Memorial Hospital/University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Chicago, IL
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
University of Illinois Hospital & Health Sciences System
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Louisville, KY
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Kosair Charities Pediatric Clinical Research Unit / University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Shreveport, LA
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Willis-Knighton Physician Network
mi
from
Shreveport, LA
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
New Brunswick, NJ
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Saint Peter's University Hospital
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Bronx, NY
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Children's Hospital at Montefiore
mi
from
Bronx, NY
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
New York, NY
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
WCMC, Department of Pediatrics - Hematology/Oncology
mi
from
New York, NY
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Stony Brook, NY
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Stony Brook University Hospital
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Greenville, NC
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Vidant Medical Center
mi
from
Greenville, NC
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Winston-Salem, NC
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
The Center for Clinical Research - Carolina Pain Institute
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Pittsburgh, PA
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Providence, RI
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Rhode Island Hospital, Department of Pediatrics
mi
from
Providence, RI
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated:  5/23/2016
mi
from
Charleston, SC
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials